PROM1 and cervical carcinoma: For patients with cervical cancer without relapse, only 3/19 patients (grey dotted lines) showed increased frequencies compared to baseline while 16/19 patients exhibited a decrease in PD-L1+ CD49f+ CD133+ CTC frequencies (grey lines).